O'Shaughnessy Asset Management’s Cytokinetics CYTK Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$571K	Buy	6,706 +1,115	+20%	+$80.1K	﹤0.01%	1537
2026 Q1	$369K	Buy	5,591 +584	+12%	+$37.1K	﹤0.01%	1679
2025 Q4	$318K	Buy	5,007 +677	+16%	+$42.1K	﹤0.01%	1742
2025 Q3	$238K	Buy	+4,330	New	+$178K	﹤0.01%	1874
2024 Q3	–	Sell	-5,091	Closed	-$276K	–	2136
2024 Q2	$276K	Buy	5,091 +63	+1%	+$3.8K	﹤0.01%	1405
2024 Q1	$353K	Buy	5,028 +2,577	+105%	+$199K	﹤0.01%	1248
2023 Q4	$205K	Buy	+2,451	New	+$88.8K	﹤0.01%	1400

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's CYTK Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Cytokinetics (CYTK) stake by 20% in Q2 2026, buying an estimated $80.1K and bringing the position to 6,706 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

O'Shaughnessy Asset Management first reported a position in CYTK in Q4 2023 and has held it in 7 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

O'Shaughnessy Asset Management held 6,706 shares of Cytokinetics worth $571K as of Q2 2026.
O'Shaughnessy Asset Management bought 1,115 Cytokinetics shares in Q2 2026, an estimated $80.1K.
Cytokinetics made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1537 holding.
O'Shaughnessy Asset Management first reported a position in Cytokinetics in Q4 2023 and has held it in 7 quarters since.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.